NCT03079999View on ClinicalTrials.gov

Study of Aspirin in Patients With Vestibular Schwannoma

PHASE2RecruitingINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

June 11, 2018

Primary Completion Date

September 30, 2025

Study Completion Date

February 28, 2029

Conditions
Vestibular SchwannomaAcoustic NeuromaNeurofibromatosis 2
Interventions
DRUG

Aspirin

Twice daily aspirin

DRUG

Placebo

Twice daily placebo

Trial Locations (6)

33136

RECRUITING

University of Miami, Miami

52242

RECRUITING

University of Iowa, Iowa City

55905

RECRUITING

Mayo Clinic, Rochester

84101

RECRUITING

University of Utah, Salt Lake City

94304

RECRUITING

Stanford Otolaryngology/HNS, Stanford

02114

RECRUITING

Massachusetts Eye and Ear, Boston

All Listed Sponsors
collaborator

United States Department of Defense

FED

lead

Massachusetts Eye and Ear Infirmary

OTHER